Anthony Martinelli

Anthony Martinelli is founder and Editor-in-Chief of The Marijuana Herald. Anthony previously served as Editor-in-Chief of TheJointBlog.com (a cannabis news site he founded in 2011 and sold in 2019), and he has worked as a campaign manager and communications director for multiple political campaigns and elected officials. Anthony can be reached at Info@TheMarijuanaHerald.com.

Author's posts

Rubicon Organics Reports Record $59.5 Million in 2025 Revenue, 22% Increase Over 2024

Rubicon Organics reported record financial results for 2025, with net revenue reaching $59.5 million, a 22% increase from the $48.7 million it generated in 2024.

Continue reading

Survey: Vast Majority of Veterinarians in Portugal Report Using CBD for Pets, High Satisfaction Across Multiple Conditions

A survey published in the Journal of Animal Physiology and Animal Nutrition by researchers from the University of Trás-os-Montes and Alto Douro finds that CBD is widely used among small animal veterinarians in Portugal, particularly for dogs and cats, with many reporting positive outcomes across a range of conditions.

Continue reading

Vireo Finalizes Acquisition of 45 Dispensaries Across Colorado and New Mexico

Vireo Growth Inc. today announced it has closed its acquisition of assets from multi-state operator Schwazze, adding dozens of dispensaries across Colorado and New Mexico.

Continue reading

Study: Novel Starch-Based Delivery System Dramatically Boosts CBD Absorption, Shows Anti-Cancer Effects in Lung Cells

New research published in the Journal of Future Foods finds that a starch-based delivery system may significantly improve how cannabidiol (CBD) is absorbed by the body, while also demonstrating notable anti-cancer activity in lung cancer cells.

Continue reading

National Institute on Aging Study Finds Cannabinoid Drug Improved Insulin Sensitivity in Men

A new study published in the American Journal of Physiology-Endocrinology and Metabolism by researchers from the National Institute on Aging at the National Institutes of Health found that the cannabinoid-related drug nabilone increased insulin sensitivity in a small group of healthy men, while a higher dose of a CB1 receptor blocker had the opposite effect.

Continue reading

U.S. Congress: All 16 Cannabis Bills Filed in the 2025-2026 Session

Sixteen bills have been filed so far during the 2025-2026 session of the United States Congress. Below is a breakdown of each one (the list does not include cannabis-related amendments filed to other bills).

Continue reading

Massachusetts Lawmakers Skeptical of Ballot Push to End Recreational Marijuana Sales

A proposed ballot measure to end legal recreational marijuana sales in Massachusetts drew skepticism Monday from lawmakers and sharp criticism from industry reps, as opponents warned it would gut a regulated market without stopping demand.

Continue reading

Illinois Marijuana Sales Reach $242 Million in 2026, Prices Down Over 30% From Early 2025

Illinois recorded $242 million in legal marijuana sales through the first two months of 2026, with prices down over 30% from a year ago.

Continue reading

Canada’s Cannabis Sales Reach CA$466 Million in January, Up Around 7% From a Year Ago

Canada’s legal marijuana market generated more than CA$466 million in retail sales in January, according to newly released data from Statistics Canada, up nearly 7% from January 2025.

Continue reading

Georgia Bill Expanding Medical Marijuana Access and Updating Patient Rules Sent to Governor Kemp

A bill that would make wide-ranging changes to Georgia’s medical marijuana law has now been sent to Governor Brian Kemp after the House voted today to agree to minor changes made by the Senate.

Continue reading